Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hasford

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
The American Journal of Cardiology|December 15, 1990
Low-dose aspirin versus anticoagulants for prevention of coronary graft occlusionM A Weber, J Hasford, C Taillens, et al.
Leukemia|September 30, 2015
Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemiaM Pfirrmann, M Baccarani, S Saussele, et al.
Leukemia|September 12, 2008
Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph/BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in GermanyM Rohrbacher, U Berger, A Hochhaus, et al.
Leukemia|December 22, 2012
Lenalidomide does not increase AML progression risk in RBC transfusion-dependent patients with Low- or Intermediate-1-risk MDS with del(5q): a comparative analysisA Kuendgen, M Lauseker, A F List, et al.
Seminars in Hematology|February 4, 2003
Prognosis and prognostic factors for patients with chronic myeloid leukemia: nontransplant therapyJ Hasford, M Pfirrmann, R Hehlmann, et al.
British Journal of Haematology|April 1, 1997
Comparative analysis of the impact of risk profile and of drug therapy on survival in CML using Sokal's index and a new score. German chronic myeloid leukaemia (CML)-Study GroupR Hehlmann, H Ansari, J Hasford, et al.
Journal of Clinical Apheresis|January 1, 1991
Plasmapheresis and subsequent pulse cyclophosphamide versus pulse cyclophosphamide alone in severe lupus: design of the LPSG trial. Lupus Plasmapheresis Study Group (LPSG)W F Clark, P C Dau, H H Euler, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|October 7, 2009
[Epidemiological methods for health services research]G Glaeske, M Augustin, H Abholz, et al.
Leukemia|April 15, 2005
Gender aspects in chronic myeloid leukemia: long-term results from randomized studiesU Berger, O Maywald, M Pfirrmann, et al.
Leukemia|February 3, 2006
Cytogenetic response to prior treatment with interferon-alpha is predictive for survival after allogeneic hematopoietic stem cell transplantation in chronic myeloid leukemiaO Maywald, M Pfirrmann, U Berger, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
The American Journal of Cardiology|December 15, 1990
Low-dose aspirin versus anticoagulants for prevention of coronary graft occlusionM A Weber, J Hasford, C Taillens, et al.
Leukemia|September 30, 2015
Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemiaM Pfirrmann, M Baccarani, S Saussele, et al.
Leukemia|September 12, 2008
Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph/BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in GermanyM Rohrbacher, U Berger, A Hochhaus, et al.
Leukemia|December 22, 2012
Lenalidomide does not increase AML progression risk in RBC transfusion-dependent patients with Low- or Intermediate-1-risk MDS with del(5q): a comparative analysisA Kuendgen, M Lauseker, A F List, et al.
Seminars in Hematology|February 4, 2003
Prognosis and prognostic factors for patients with chronic myeloid leukemia: nontransplant therapyJ Hasford, M Pfirrmann, R Hehlmann, et al.
British Journal of Haematology|April 1, 1997
Comparative analysis of the impact of risk profile and of drug therapy on survival in CML using Sokal's index and a new score. German chronic myeloid leukaemia (CML)-Study GroupR Hehlmann, H Ansari, J Hasford, et al.
Journal of Clinical Apheresis|January 1, 1991
Plasmapheresis and subsequent pulse cyclophosphamide versus pulse cyclophosphamide alone in severe lupus: design of the LPSG trial. Lupus Plasmapheresis Study Group (LPSG)W F Clark, P C Dau, H H Euler, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|October 7, 2009
[Epidemiological methods for health services research]G Glaeske, M Augustin, H Abholz, et al.
Leukemia|April 15, 2005
Gender aspects in chronic myeloid leukemia: long-term results from randomized studiesU Berger, O Maywald, M Pfirrmann, et al.
Leukemia|February 3, 2006
Cytogenetic response to prior treatment with interferon-alpha is predictive for survival after allogeneic hematopoietic stem cell transplantation in chronic myeloid leukemiaO Maywald, M Pfirrmann, U Berger, et al.
Pageof 11